0 Comentários
0 Compartilhamentos
919 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Drug Repurposing For Mitochondrial Disorders Market Overview: Key Drivers and Challenges 2025 –2032According to the latest report published by Data Bridge Market Research, the Drug Repurposing For Mitochondrial Disorders Market CAGR Value The global drug repurposing for mitochondrial disorders market size was valued at USD 71.23 million in 2024 and is expected to reach USD 110.14 million by 2032, at a CAGR of 5.60% during the forecast...0 Comentários 0 Compartilhamentos 197 Visualizações 0 Anterior
-
AI Drug Repurposing Market Growth, Driving Factors, Strategies, Trends, Forecast Analysis By Fact.MRU.S. AI Drug Repurposing Market Gains Momentum as Pfizer Expands AI-Driven Drug Discovery, with Global Market Rising from USD 1.5 billion in 2026 to USD 8.8 billion by 2036 at a 19.4% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The AI drug repurposing market crossed a valuation of USD 1.3 billion in 2025. Demand is projected to increase from USD 1.5 billion in 2026...0 Comentários 0 Compartilhamentos 84 Visualizações 0 Anterior
-
AI Drug Repurposing Market Outlook | Generative AI Revolutionizing Drug DevelopmentMarket Overview The AI-based Drug Repurposing Market is emerging as one of the fastest-growing segments within the pharmaceutical and artificial intelligence industries, driven by the need to accelerate drug discovery while reducing development costs and timelines. AI-powered drug repurposing leverages machine learning, deep learning, natural language processing (NLP), and predictive analytics...0 Comentários 0 Compartilhamentos 230 Visualizações 0 Anterior
-
AI in Drug Repurposing Market and the Search for Faster Clinical CandidatesThe global artificial intelligence (AI) in drug repurposing market was valued at USD 1.3 billion in 2025 and is estimated to reach USD 1.7 billion in 2026. The market is projected to expand to USD 7.7 billion by 2033, registering a 24.5% CAGR from 2026 to 2033. North America accounted for the largest revenue share at 52.9% in 2025, supported by a strong...0 Comentários 0 Compartilhamentos 99 Visualizações 0 Anterior
-
AI in Drug Repurposing Market Growth Outlook: Revenue Expected to Reach USD 6.30 Billion by 2034Market Overview Polaris Market Research’s latest research report, titled AI in Drug Repurposing Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth projections. In a market...0 Comentários 0 Compartilhamentos 167 Visualizações 0 Anterior
-
AI in Drug Repurposing Market To Witness Massive GrowthArtificial intelligence is transforming pharmaceutical research by enabling researchers to identify new therapeutic applications for existing medicines more efficiently. AI in Drug Discovery is helping pharmaceutical and biotechnology companies analyze large volumes of biological, chemical, genomic, and clinical information to identify potential drug-disease relationships. Drug...0 Comentários 0 Compartilhamentos 67 Visualizações 0 Anterior
-
AI in Drug Repurposing Market To Witness Massive Growth By 2033Drug repurposing is emerging as an important strategy in modern pharmaceutical research because it can identify new therapeutic uses for existing medicines and potentially reduce the time, cost, and uncertainty associated with conventional drug development. The latest trend is the integration of artificial intelligence, machine learning, generative AI, and large-scale biomedical datasets into...0 Comentários 0 Compartilhamentos 88 Visualizações 0 Anterior
-
Drug Repurposing for Mitochondrial Disorders Market Analysis and Future Forecast"Global Executive Summary Drug Repurposing For Mitochondrial Disorders Market: Size, Share, and Forecast The global drug repurposing for mitochondrial disorders market size was valued at USD 71.23 million in 2024 and is expected to reach USD 110.14 million by 2032, at a CAGR of 5.60% during the forecast period While preparing the first class Drug...0 Comentários 0 Compartilhamentos 700 Visualizações 0 Anterior
-
Drug Repurposing Market Size, Industry Outlook, AI and Precision Medicine Trends, Competitive Analysis, and Future Forecast 2026–2033Accelerating R&D Efficiency: Global Drug Repurposing Market Poised for Resilient Expansion, Driven by AI-Powered Discovery and Cost-Mitigation Strategies The global pharmaceutical and biopharmaceutical research sector is experiencing a monumental paradigm shift. In an era defined by skyrocketing drug development costs, narrowing patent cliffs, and pressing unmet medical needs across...0 Comentários 0 Compartilhamentos 465 Visualizações 0 Anterior
-
North America Drug Repurposing Market Demand, Innovations and Growth Prospects 2034North America Drug Repurposing Market is experiencing robust growth owing to the increasing need for cost-effective and time-efficient drug development strategies, rising prevalence of chronic and rare diseases, and strong investments in pharmaceutical research and development. The region benefits from a well-established biotechnology ecosystem, advanced clinical research infrastructure,...0 Comentários 0 Compartilhamentos 236 Visualizações 0 Anterior
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali